D. Hobson, R. L. Curry, A. S. Beare, and A. Ward-gardner, The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses, J. Hyg, vol.70, pp.767-777, 1972.

S. Sasaki, M. C. Jaimes, T. H. Holmes, C. L. Dekker, K. Mahmood et al., Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines, J. Virol, vol.81, pp.215-228, 2007.

J. Wrammert, K. Smith, J. Miller, W. A. Langley, K. Kokko et al., Rapid cloning of highaffinity human monoclonal antibodies against influenza virus, Nature, vol.453, pp.667-671, 2008.

B. P. Arulanandam, R. H. Raeder, J. G. Nedrud, D. J. Bucher, J. Le et al., IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection, J. Immunol, vol.166, pp.226-231, 2001.

A. C. Monsalvo, J. P. Batalle, M. F. Lopez, J. C. Krause, J. Klemenc et al., Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes, Nat. Med, vol.17, pp.195-199, 2011.

K. B. Renegar, P. A. Small, L. G. Boykins, and P. F. Wright, Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract, J. Immunol, vol.173, pp.1978-1986, 2004.

S. Khurana, N. Verma, K. R. Talaat, R. A. Karron, and H. Golding, Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender, J. Infect. Dis, vol.205, pp.610-620, 2012.

H. E. Larson, D. A. Tyrrell, C. H. Bowker, C. W. Potter, and G. C. Schild, Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2), J. Hyg, vol.80, pp.243-248, 1978.

A. J. Mcmichael, F. M. Gotch, D. W. Dongworth, A. Clark, and C. W. Potter, Declining T-cell immunity to influenza, Lancet, vol.2, pp.762-764, 1983.
DOI : 10.1016/s0140-6736(83)92297-3

R. A. Seder, P. A. Darrah, and M. Roederer, T-cell quality in memory and protection: implications for vaccine design, Nat. Rev. Immunol, vol.8, pp.247-258, 2008.
DOI : 10.1038/nri2274

L. E. Wagar, L. Rosella, N. Crowcroft, B. Lowcock, P. C. Drohomyrecky et al., Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination, PLoS ONE, vol.6, p.28063, 2011.

A. J. Mcmichael and B. A. Askonas, Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell, Eur. J. Immunol, vol.8, pp.705-711, 1978.

A. J. Mcmichael, F. M. Gotch, G. R. Noble, and P. A. Beare, Cytotoxic T-cell immunity to influenza, N. Engl. J. Med, vol.309, pp.13-17, 1983.

S. A. Plotkin, Vaccines: correlates of vaccine-induced immunity, Clin. Infect. Dis, vol.47, pp.401-409, 2008.
DOI : 10.1086/589862
URL : https://academic.oup.com/cid/article-pdf/47/3/401/898295/47-3-401.pdf

G. T. Belz, D. Wodarz, G. Diaz, M. A. Nowak, and P. C. Doherty, Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-celldeficient mice, J. Virol, vol.76, pp.12388-12393, 2002.
DOI : 10.1128/jvi.76.23.12388-12393.2002
URL : https://jvi.asm.org/content/76/23/12388.full.pdf

M. Eichelberger, W. Allan, M. Zijlstra, R. Jaenisch, and P. C. Doherty, Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells, J. Exp. Med, vol.174, pp.875-880, 1991.

W. E. Biddison, S. Shaw, and D. L. Nelson, Virus specificity of human influenza virus-immune cytotoxic T cells, J. Immunol, vol.122, pp.660-664, 1979.

J. A. Greenbaum, M. F. Kotturi, Y. Kim, C. Oseroff, K. Vaughan et al., Preexisting immunity against swine-origin H1N1 influenza viruses in the general human population, Proc. Natl. Acad. Sci. USA, vol.106, pp.20365-20370, 2009.
DOI : 10.1073/pnas.0911580106
URL : http://www.pnas.org/content/106/48/20365.full.pdf

A. P. Kendal and T. R. Cate, Increased sensitivity and reduced specificity of hemagglutination inhibition tests with ether-treated influenza B/Singapore/ 222/79, J. Clin. Microbiol, vol.18, pp.930-934, 1983.

J. D. Dimitrov, S. Lacroix-desmazes, and S. V. Kaveri, Important parameters for evaluation of antibody avidity by immunosorbent assay, Anal. Biochem, vol.418, pp.149-151, 2011.

S. Crotty, R. D. Aubert, J. Glidewell, and R. Ahmed, Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system, J. Immunol. Methods, vol.286, pp.111-122, 2004.
DOI : 10.1016/j.jim.2003.12.015

A. I. Saeed, V. Sharov, J. White, J. Li, W. Liang et al., TM4: a free, open-source system for microarray data management and analysis, Biotechniques, vol.34, pp.374-378, 2003.
DOI : 10.2144/03342mt01

K. Y. Yeung, D. R. Haynor, and W. L. Ruzzo, Validating clustering for gene expression data, Bioinformatics, vol.17, pp.309-318, 2001.
DOI : 10.1093/bioinformatics/17.4.309
URL : https://academic.oup.com/bioinformatics/article-pdf/17/4/309/937074/170309.pdf

A. Soukas, P. Cohen, N. D. Socci, and J. M. Friedman, Leptin-specific patterns of gene expression in white adipose tissue, Genes Dev, vol.14, pp.963-980, 2000.

M. E. Greenberg, M. H. Lai, G. F. Hartel, C. H. Wichems, C. Gittleson et al., Response to a monovalent 2009 influenza A (H1N1) vaccine, N. Engl. J. Med, vol.361, pp.2405-2413, 2009.
DOI : 10.1056/nejmoa0907413

K. Hancock, V. Veguilla, X. Lu, W. Zhong, E. N. Butler et al., Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus, N. Engl. J. Med, vol.361, pp.1945-1952, 2009.

A. S. Madhun, P. E. Akselsen, H. Sjursen, G. Pedersen, S. Svindland et al., An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers, Vaccine, vol.29, pp.266-273, 2010.
DOI : 10.1016/j.vaccine.2010.10.038

F. Roman, T. Vaman, B. Gerlach, A. Markendorf, P. Gillard et al., Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial, Vaccine, vol.28, pp.1740-1745, 2010.

A. Daffertshofer, C. J. Lamoth, O. G. Meijer, and P. J. Beek, PCA in studying coordination and variability: a tutorial, Clin. Biomech, vol.19, pp.415-428, 2004.

J. C. Roden, B. W. King, D. Trout, A. Mortazavi, B. J. Wold et al., Mining gene expression data by interpreting principal components, BMC Bioinformatics, vol.7, p.194, 2006.

F. Roman, F. Clément, W. Dewé, K. Walravens, C. Maes et al., Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials, Clin. Vaccine Immunol, vol.18, pp.835-843, 2011.

B. Combadiere and C. Liard, Transcutaneous and intradermal vaccination, Hum. Vaccin, vol.7, pp.811-827, 2011.

P. Durando, R. Iudici, C. Alicino, M. Alberti, D. De-florentis et al., Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine, Hum. Vaccin, vol.7, pp.29-40, 2011.

D. M. Brown, A. M. Dilzer, D. L. Meents, and S. L. Swain, CD4 T cellmediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch, J. Immunol, vol.177, pp.2888-2898, 2006.

P. C. Doherty, S. J. Turner, R. G. Webby, and P. G. Thomas, Influenza and the challenge for immunology, Nat. Immunol, vol.7, pp.449-455, 2006.

T. M. Strutt, K. K. Mckinstry, J. P. Dibble, C. Winchell, Y. Kuang et al., Memory CD4+ T cells induce innate responses independently of pathogen, Nat. Med, vol.16, pp.1-564, 2010.

G. Galli, D. Medini, E. Borgogni, L. Zedda, M. Bardelli et al., Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels, Proc. Natl. Acad. Sci. USA, vol.106, pp.3877-3882, 2009.

C. Pelat, A. Falchi, F. Carrat, A. Mosnier, I. Bonmarin et al., Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France, PLoS ONE, vol.6, p.19621, 2011.

A. S. Monto and A. P. , Effect of neuraminidase antibody on Hong Kong influenza, Lancet, vol.1, pp.623-625, 1973.

T. M. Wilkinson, C. K. Li, C. S. Chui, A. K. Huang, M. Perkins et al., Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans, Nat. Med, vol.18, pp.274-280, 2012.

H. T. Maecker, J. P. Mccoy, and R. Nussenblatt, Standardizing immunophenotyping for the Human Immunology Project, Nat. Rev. Immunol, vol.12, pp.191-200, 2012.

A. Monaco, F. M. Marincola, M. Sabatino, Z. Pos, M. L. Tornesello et al., Molecular immune signatures of HIV-1 vaccines in human PBMCs, FEBS Lett, vol.583, pp.3004-3008, 2009.

H. I. Nakaya, J. Wrammert, E. K. Lee, L. Racioppi, S. Marie-kunze et al., Systems biology of vaccination for seasonal influenza in humans, Nat. Immunol, vol.12, pp.786-795, 2011.

T. D. Querec, R. S. Akondy, E. K. Lee, W. Cao, H. I. Nakaya et al., Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans, Nat. Immunol, vol.10, pp.116-125, 2009.

E. Aricò, E. Wang, M. L. Tornesello, M. Tagliamonte, G. K. Lewis et al., Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation, J. Transl. Med, vol.3, p.45, 2005.

L. Buonaguro, A. Monaco, E. Aricò, E. Wang, M. L. Tornesello et al., Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation, BMC Bioinformatics, vol.9, p.5, 2008.

D. Gaucher, R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher et al., Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses, J. Exp. Med, vol.205, pp.3119-3131, 2008.